Highlights and Quick Summary
- EPS Growth (diluted) for the quarter ending September 30, 2022 was 12.26% (a -86.28% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (diluted) increased by Infinity%
- Annual EPS Growth (diluted) for 2021 was -2.63% (a -95.06% decrease from previous year)
- Annual EPS Growth (diluted) for 2020 was -53.23% (a 213.49% increase from previous year)
- Annual EPS Growth (diluted) for 2019 was -16.98% (a -97.09% decrease from previous year)
Visit stockrow.com/BBIO
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (diluted) of BridgeBio Pharma, Inc.
Most recent EPS Growth (diluted)of BBIO including historical data for past 10 years.Interactive Chart of EPS Growth (diluted) of BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 12.26% | 89.39% | -14.41% | – |
| 2021 | 0.0% | -8.16% | 35.92% | -51.28% | -2.63% |
| 2020 | -62.9% | -92.16% | -56.06% | 33.9% | -53.23% |
| 2019 | – | – | 38.61% | 47.96% | -16.98% |
| 2018 | – | – | – | – | -583.87% |
| 2017 | – | – | – | – | 85.38% |
Business Profile of BridgeBio Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology